Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AXSM
Stock Latest News
The Fly
Axsome Therapeutics price target raised to $259 from $251 at UBS
19d ago
AXSM
Premium
Ratings
Axsome Therapeutics: Auvelity’s Best‑in‑Class Potential in Alzheimer’s Agitation Supports Buy Rating
20d ago
AXSM
Premium
Company Announcements
Axsome acquires global rights to Takeda’s balipodect
28d ago
8K
AXSM
Premium
The Fly
Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
28d ago
TAK
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $245 from $220 at Guggenheim
1M ago
AXSM
Premium
Market News
3 Best Growth Stocks to Buy This Week, According to Analysts – March 16-20
1M ago
WIX
AXSM
Premium
Ratings
Axsome Therapeutics: Strong AUVELITY/SUNOSI Momentum and Rich Late-Stage Pipeline Underpin Buy Rating
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $222 from $219 at RBC Capital
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $251 from $248 at UBS
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $207 from $204 at Morgan Stanley
2M ago
AXSM
Premium
The Fly
Axsome announces first patient dosed in CLARITY Phase 3 trial of solriamfetol
2M ago
AXSM
Premium
The Fly
Axsome announces first patient dosed in CLARITY Phase 3 trial of solriamfetol
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $220 from $205 at Guggenheim
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $202 from $193 at Wells Fargo
2M ago
AXSM
Premium
Ratings
Axsome Therapeutics: Auvelity Growth and Alzheimer’s Agitation Upside Support Buy Rating and $214 Target
2M ago
AXSM
Premium
Company Announcements
Axsome Therapeutics Signals Strong Growth in Earnings Call
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics initiated with an Outperform at Wolfe Research
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $215 from $195 at TD Cowen
2M ago
AXSM
Premium
The Fly
Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
2M ago
D
DE
Premium
Ratings
Axsome Therapeutics: Buy Rating on Solid Execution, Sufficient Cash Runway, and Advancing Late‑Stage Pipeline
2M ago
AXSM
Premium
Ratings
Buy Rating on Axsome: Strong Commercial Momentum, Expanding CNS Pipeline, and Attractive Valuation Upside
2M ago
AXSM
Premium
The Fly
Axsome Therapeutics reports Q4 EPS (56c), consensus (73c)
2M ago
AXSM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
